Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on May 27, 2025
Restoring Sight: Amigos Internacionales & Doctors on Mission Bring Hope to Uganda’s Blind
EIN Presswire
·
May 27, 2025
Over 750 patients treated and 90 cataract surgeries completed in Buhweju, Uganda. Amigos and Doctors on Mission are restoring sight—and hope. COMMERCE, TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In the remote district of Buhweju in …
Galen College of Nursing Celebrates Grand Opening of New San Antonio Campus
EIN Presswire
·
May 27, 2025
Access to nursing education in the Lone Star State takes a big leap forward today as Galen College celebrates the Grand Opening of its new San Antonio campus. SAN ANTONIO, TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Access to quality nursing …
CPR Certification Labs Selected by American Heart Association as an Exclusive Partner for RQI CPR Training
EIN Presswire
·
May 27, 2025
Accuracy, Convenience, and Efficiency: CPR Certification Labs and RQI Technology are The Future of American Heart Association CPR, BLS, ACLS, and PALS Training TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- CPR Certification Labs, a leading …
Aesthetic Record Partners with Sunbit to Eliminate Payment Barriers and Transform the Patient Financing Experience
EIN Presswire
·
May 27, 2025
No more lost revenue: Aesthetic practices get instant, fully integrated patient financing through Aesthetic Record x Sunbit strategic partnership DALLAS, TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Aesthetic Record, the industry-leading EMR …
Aja Health and Wellness Inc. Announces Launch of Nasal Product for Migraine Headache Relief and Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
May 27, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly owned subsidiary Aja Therapeutics Inc. ("ATI") is …
CompuGroup Medical’s CGM AMBI named 'Best AI-Assisted Software Solution' in 9th annual MedTech Breakthrough Awards
EIN Presswire
·
May 27, 2025
Prestigious, international awards program recognizes standout digital health and medical technology AUSTIN, TX, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- CompuGroup Medical US (CGM), a leading provider of innovative healthcare IT solutions and …
Jamieson Wellness Inc. Announces Voting Results from 2025 Annual Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 10, 2025 was …
Yerbaé Partners with National Foodservice Provider, Guckenheimer
GlobeNewswire
·
May 27, 2025
New partnership brings Yerbaé’s functional beverages to Guckenheimer’s national café …
Aptose Announces Results from Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
SAN DIEGO and TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2025 (the “Meeting”). The …
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
GlobeNewswire
·
May 27, 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging …
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City …
Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
GlobeNewswire
·
May 27, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global …
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it …
Dentsply Sirona Declares Quarterly Cash Dividend
GlobeNewswire
·
May 27, 2025
CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate …
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 27, 2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …